Clinical Trial Update: Irish Omega-3 Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on using omega-3 fatty acids for psychotic disorders; current trial status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psychotic Disorders

Drugs mentioned

• Omega-3 fatty acids (omega-3 fatty acids)

Snippet

Sponsor: University College Cork | Conditions: Psychotic Disorders | Phase 2 | Status: UNKNOWN